MedTrace Logo

Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

NCT04778592 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 149

Last updated 2023-11-07

Study results available
· View outcomes & findings →

Summary

Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain

Conditions

  • Lumbosacral Radiculopathy

Interventions

DRUG

ETX-018810

Study Drug

DRUG

Placebo

Placebo

Sponsors & Collaborators

  • Eliem Therapeutics (UK) Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-19
Primary Completion
2022-05-16
Completion
2022-05-25
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04778592 on ClinicalTrials.gov